FILENAME: pubmed_diabetes_review1.txt
SOURCE: PubMed (National Library of Medicine)
TITLE: Pathophysiology and Emerging Therapeutic Strategies in Type 2 Diabetes: A 2024 Update
JOURNAL: J Clin Endocrinol Metab. 2024 Mar; 109(3): 88-102.
TYPE: Review Article

ABSTRACT
-----------------------------------------------------------------------------
BACKGROUND: 
Type 2 Diabetes Mellitus (T2DM) is a complex, multifactorial metabolic 
disorder characterized by chronic hyperglycemia, insulin resistance, and 
progressive beta-cell failure. While traditional models focused primarily on 
the "triumvirate" of muscle, liver, and beta-cell dysfunction, recent 
evidence suggests a much broader pathophysiological basis, often referred to 
as the "Ominous Octet." This review examines the latest advances in understanding 
these mechanisms and their implications for modern pharmacotherapy.

METHODS: 
We conducted a comprehensive search of PubMed and EMBASE for high-impact 
reviews and clinical trials published between 2020 and 2024. Emphasis was 
placed on the role of the gut microbiome, incretin defects, and renal glucose 
handling.

RESULTS: 
Current research highlights that hyperglycemia in T2DM is driven by defects 
in at least eight distinct organs: (1) decreased insulin secretion (pancreas), 
(2) decreased incretin effect (gut), (3) increased lipolysis (fat), (4) 
increased glucose reabsorption (kidney), (5) increased hepatic glucose 
production (liver), (6) neurotransmitter dysfunction (brain), (7) muscle 
insulin resistance, and (8) elevated glucagon secretion (alpha-cells). 
Therapeutic agents such as SGLT-2 inhibitors and GLP-1 receptor agonists 
address these defects more comprehensively than older agents like sulfonylureas.

CONCLUSION: 
The management of T2DM has shifted from a "glucocentric" approach (lowering 
sugar) to a "cardio-renal-metabolic" approach. Early combination therapy 
targeting multiple pathophysiological pathways is now recommended to preserve 
beta-cell function and reduce long-term cardiovascular mortality.